Large B Cell Lymphoma With Irf4 Rearrangement clinical trials

Explore recruiting large b cell lymphoma with irf4 rearrangement clinical trials.

Recruiting large b cell lymphoma with irf4 rearrangement studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Large B Cell Lymphoma With Irf4 Rearrangement trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, Open-label, Phase 3 Study of Acalabrutinib in Combination with Rituximab and Reduced Dose CHOP (R-miniCHOP) in Older Adults with Untreated Diffuse Large B-Cell Lymphoma (ARCHED/GLA 2022-1)

Germany, Greece

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase 1, open-label, multicenter, dose escalation study of SRG-1505 as monotherapy in subjects with mature b-cell malignancies

France, Poland, Romania, Italy, Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Large B Cell Lymphoma With Irf4 Rearrangement trials by city

Large B Cell Lymphoma With Irf4 Rearrangement in Toronto Large B Cell Lymphoma With Irf4 Rearrangement in Vancouver Large B Cell Lymphoma With Irf4 Rearrangement in Montreal Large B Cell Lymphoma With Irf4 Rearrangement in Calgary Large B Cell Lymphoma With Irf4 Rearrangement in Edmonton Large B Cell Lymphoma With Irf4 Rearrangement in Ottawa Large B Cell Lymphoma With Irf4 Rearrangement in Winnipeg Large B Cell Lymphoma With Irf4 Rearrangement in Quebec City Large B Cell Lymphoma With Irf4 Rearrangement in Hamilton Large B Cell Lymphoma With Irf4 Rearrangement in Kitchener Large B Cell Lymphoma With Irf4 Rearrangement in London Large B Cell Lymphoma With Irf4 Rearrangement in Halifax Large B Cell Lymphoma With Irf4 Rearrangement in New York Large B Cell Lymphoma With Irf4 Rearrangement in Los Angeles Large B Cell Lymphoma With Irf4 Rearrangement in Chicago Large B Cell Lymphoma With Irf4 Rearrangement in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease